

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RNA destabilization (GO:0050779) | 6.54829268 |
| 2 | positive regulation of protein deacetylation (GO:0090312) | 5.43401561 |
| 3 | tryptophan catabolic process (GO:0006569) | 4.51940856 |
| 4 | indole-containing compound catabolic process (GO:0042436) | 4.51940856 |
| 5 | indolalkylamine catabolic process (GO:0046218) | 4.51940856 |
| 6 | cell wall macromolecule metabolic process (GO:0044036) | 4.51170375 |
| 7 | tryptophan metabolic process (GO:0006568) | 4.29661741 |
| 8 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 4.26064096 |
| 9 | cell wall macromolecule catabolic process (GO:0016998) | 4.21519237 |
| 10 | ovulation from ovarian follicle (GO:0001542) | 3.97933173 |
| 11 | retinal ganglion cell axon guidance (GO:0031290) | 3.95973180 |
| 12 | regulation of cilium movement (GO:0003352) | 3.86194776 |
| 13 | kynurenine metabolic process (GO:0070189) | 3.73981693 |
| 14 | somite rostral/caudal axis specification (GO:0032525) | 3.63321443 |
| 15 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.51195095 |
| 16 | acrosome reaction (GO:0007340) | 3.49461511 |
| 17 | response to misfolded protein (GO:0051788) | 3.46087209 |
| 18 | left/right axis specification (GO:0070986) | 3.40446586 |
| 19 | sperm motility (GO:0030317) | 3.38875388 |
| 20 | cellular ketone body metabolic process (GO:0046950) | 3.35699332 |
| 21 | positive regulation of action potential (GO:0045760) | 3.35275080 |
| 22 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.35067681 |
| 23 | negative regulation of macroautophagy (GO:0016242) | 3.31345944 |
| 24 | negative regulation of viral entry into host cell (GO:0046597) | 3.30866329 |
| 25 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.30628084 |
| 26 | forebrain neuron development (GO:0021884) | 3.23876600 |
| 27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.23432952 |
| 28 | amine catabolic process (GO:0009310) | 3.20248076 |
| 29 | cellular biogenic amine catabolic process (GO:0042402) | 3.20248076 |
| 30 | indolalkylamine metabolic process (GO:0006586) | 3.11377389 |
| 31 | regulation of protein deacetylation (GO:0090311) | 3.10176064 |
| 32 | peptide catabolic process (GO:0043171) | 3.08203744 |
| 33 | membrane budding (GO:0006900) | 3.02929359 |
| 34 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.02823508 |
| 35 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.99067147 |
| 36 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.95007464 |
| 37 | mature B cell differentiation involved in immune response (GO:0002313) | 2.93933041 |
| 38 | prenylation (GO:0097354) | 2.93638581 |
| 39 | protein prenylation (GO:0018342) | 2.93638581 |
| 40 | negative regulation of lipid storage (GO:0010888) | 2.93097133 |
| 41 | virion attachment to host cell (GO:0019062) | 2.88409974 |
| 42 | adhesion of symbiont to host cell (GO:0044650) | 2.88409974 |
| 43 | heart contraction (GO:0060047) | 2.85336090 |
| 44 | heart process (GO:0003015) | 2.85336090 |
| 45 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.83881149 |
| 46 | epithelial cilium movement (GO:0003351) | 2.82302658 |
| 47 | regulation of microtubule-based movement (GO:0060632) | 2.82094870 |
| 48 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.79542853 |
| 49 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.78367821 |
| 50 | negative regulation of protein localization to cell surface (GO:2000009) | 2.77032393 |
| 51 | ketone body metabolic process (GO:1902224) | 2.76558303 |
| 52 | multicellular organism reproduction (GO:0032504) | 2.72853628 |
| 53 | oligosaccharide catabolic process (GO:0009313) | 2.72764038 |
| 54 | interferon-gamma production (GO:0032609) | 2.72311999 |
| 55 | circadian sleep/wake cycle process (GO:0022410) | 2.71170310 |
| 56 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.71082495 |
| 57 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.67921753 |
| 58 | regulation of viral entry into host cell (GO:0046596) | 2.67851551 |
| 59 | interkinetic nuclear migration (GO:0022027) | 2.65671577 |
| 60 | myelin assembly (GO:0032288) | 2.65261912 |
| 61 | ADP metabolic process (GO:0046031) | 2.53949620 |
| 62 | substrate-dependent cell migration (GO:0006929) | 2.53452668 |
| 63 | arachidonic acid secretion (GO:0050482) | 2.53408874 |
| 64 | icosanoid secretion (GO:0032309) | 2.53408874 |
| 65 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.53214913 |
| 66 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.52875497 |
| 67 | cell adhesion mediated by integrin (GO:0033627) | 2.52337585 |
| 68 | keratan sulfate catabolic process (GO:0042340) | 2.51402525 |
| 69 | ovulation (GO:0030728) | 2.50720014 |
| 70 | activation of protein kinase B activity (GO:0032148) | 2.48659094 |
| 71 | positive regulation of gastrulation (GO:2000543) | 2.47801056 |
| 72 | plasma membrane fusion (GO:0045026) | 2.47606710 |
| 73 | response to folic acid (GO:0051593) | 2.47560595 |
| 74 | establishment of protein localization to Golgi (GO:0072600) | 2.46194550 |
| 75 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.44148383 |
| 76 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.42954319 |
| 77 | aromatic amino acid family catabolic process (GO:0009074) | 2.40879231 |
| 78 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.39847043 |
| 79 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.39758983 |
| 80 | negative regulation of amino acid transport (GO:0051956) | 2.39189560 |
| 81 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.37909185 |
| 82 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.35900580 |
| 83 | regulation of mononuclear cell migration (GO:0071675) | 2.34310910 |
| 84 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.33552265 |
| 85 | carnitine shuttle (GO:0006853) | 2.31859345 |
| 86 | adhesion of symbiont to host (GO:0044406) | 2.31151190 |
| 87 | hemoglobin metabolic process (GO:0020027) | 2.30172221 |
| 88 | short-term memory (GO:0007614) | 2.30150514 |
| 89 | cardiac myofibril assembly (GO:0055003) | 2.29961326 |
| 90 | negative regulation of chemotaxis (GO:0050922) | 2.29746904 |
| 91 | myofibril assembly (GO:0030239) | 2.29661843 |
| 92 | protein polyglutamylation (GO:0018095) | 2.29616046 |
| 93 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.28573528 |
| 94 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.28339263 |
| 95 | positive regulation of lipid storage (GO:0010884) | 2.26814135 |
| 96 | amino sugar catabolic process (GO:0046348) | 2.26565792 |
| 97 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.25967847 |
| 98 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.25967847 |
| 99 | regulation of lipid storage (GO:0010883) | 2.25920509 |
| 100 | motile cilium assembly (GO:0044458) | 2.25650157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.46574623 |
| 2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.39880234 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.24754578 |
| 4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.97204480 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.56853241 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.51003219 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.25987077 |
| 8 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.19607312 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.19575574 |
| 10 | TP53_16413492_ChIP-PET_HCT116_Human | 2.18798748 |
| 11 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.17257857 |
| 12 | FUS_26573619_Chip-Seq_HEK293_Human | 2.16764324 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.07054796 |
| 14 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.04474808 |
| 15 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.03598749 |
| 16 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.02311778 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.95943470 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.91377303 |
| 19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.89517214 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.88023158 |
| 21 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.86961113 |
| 22 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.86961113 |
| 23 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.85634619 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.84504537 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.81348321 |
| 26 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77064906 |
| 27 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.70503304 |
| 28 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66828602 |
| 29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.65577987 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.60447931 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.60346377 |
| 32 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.58949844 |
| 33 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.55920889 |
| 34 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.55920889 |
| 35 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.54965567 |
| 36 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.53541904 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51420477 |
| 38 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.51093070 |
| 39 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.50967215 |
| 40 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.48583159 |
| 41 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.44702406 |
| 42 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44282171 |
| 43 | VDR_22108803_ChIP-Seq_LS180_Human | 1.44226262 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43759773 |
| 45 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.40752798 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40414245 |
| 47 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.39999659 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.39999659 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.39905127 |
| 50 | KDM2B_26808549_Chip-Seq_REH_Human | 1.39448878 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37264318 |
| 52 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.37093846 |
| 53 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.36977244 |
| 54 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.36700958 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34475165 |
| 56 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.33299966 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31660722 |
| 58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31495124 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31299101 |
| 60 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.31269847 |
| 61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30716814 |
| 62 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30164376 |
| 63 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.30111452 |
| 64 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28276618 |
| 65 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27767634 |
| 66 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.27023995 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26952199 |
| 68 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26377381 |
| 69 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25063082 |
| 70 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.22482052 |
| 71 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21837174 |
| 72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21317376 |
| 73 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20625475 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19724737 |
| 75 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19724737 |
| 76 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.19584296 |
| 77 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.19546293 |
| 78 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17753701 |
| 79 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.14843280 |
| 80 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13928530 |
| 81 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11627573 |
| 82 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.11130184 |
| 83 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.10815694 |
| 84 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.10067255 |
| 85 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.07717419 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06683907 |
| 87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06280503 |
| 88 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05369386 |
| 89 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05210808 |
| 90 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.04816656 |
| 91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04476294 |
| 92 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04348889 |
| 93 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03382971 |
| 94 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03020797 |
| 95 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02415389 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99710957 |
| 97 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99243654 |
| 98 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98590242 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98398864 |
| 100 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97785082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003950_abnormal_plasma_membrane | 3.98837146 |
| 2 | MP0005670_abnormal_white_adipose | 3.83850579 |
| 3 | MP0010368_abnormal_lymphatic_system | 3.34345430 |
| 4 | MP0003183_abnormal_peptide_metabolism | 3.00345015 |
| 5 | MP0001501_abnormal_sleep_pattern | 2.94807186 |
| 6 | MP0003195_calcinosis | 2.63228982 |
| 7 | MP0005410_abnormal_fertilization | 2.60881083 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.50828225 |
| 9 | MP0004510_myositis | 2.43132094 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.42313162 |
| 11 | MP0003646_muscle_fatigue | 2.34495189 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.21300798 |
| 13 | MP0004215_abnormal_myocardial_fiber | 2.20413581 |
| 14 | MP0005666_abnormal_adipose_tissue | 2.20394449 |
| 15 | MP0004272_abnormal_basement_membrane | 2.16551013 |
| 16 | MP0005367_renal/urinary_system_phenotyp | 2.13369496 |
| 17 | MP0000516_abnormal_urinary_system | 2.13369496 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 2.12114609 |
| 19 | MP0003890_abnormal_embryonic-extraembry | 2.01974838 |
| 20 | MP0008961_abnormal_basal_metabolism | 1.98745626 |
| 21 | MP0008004_abnormal_stomach_pH | 1.94020180 |
| 22 | MP0005375_adipose_tissue_phenotype | 1.88615286 |
| 23 | MP0000013_abnormal_adipose_tissue | 1.86626743 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.81430246 |
| 25 | MP0009840_abnormal_foam_cell | 1.77465218 |
| 26 | MP0003879_abnormal_hair_cell | 1.76021293 |
| 27 | MP0001958_emphysema | 1.75662883 |
| 28 | MP0006054_spinal_hemorrhage | 1.71535312 |
| 29 | MP0000749_muscle_degeneration | 1.70104299 |
| 30 | MP0005275_abnormal_skin_tensile | 1.65258230 |
| 31 | MP0000372_irregular_coat_pigmentation | 1.64008755 |
| 32 | MP0003279_aneurysm | 1.54690583 |
| 33 | MP0010386_abnormal_urinary_bladder | 1.46216546 |
| 34 | MP0005595_abnormal_vascular_smooth | 1.41295152 |
| 35 | MP0004036_abnormal_muscle_relaxation | 1.37453076 |
| 36 | MP0009115_abnormal_fat_cell | 1.32990484 |
| 37 | MP0002127_abnormal_cardiovascular_syste | 1.30664747 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.29553349 |
| 39 | MP0006082_CNS_inflammation | 1.29106091 |
| 40 | MP0005257_abnormal_intraocular_pressure | 1.22000153 |
| 41 | MP0005620_abnormal_muscle_contractility | 1.19918833 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.19078406 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.18608390 |
| 44 | MP0001853_heart_inflammation | 1.15014420 |
| 45 | MP0001542_abnormal_bone_strength | 1.12565706 |
| 46 | MP0003690_abnormal_glial_cell | 1.12000685 |
| 47 | MP0001485_abnormal_pinna_reflex | 1.11841629 |
| 48 | MP0003724_increased_susceptibility_to | 1.11436654 |
| 49 | MP0000604_amyloidosis | 1.11047419 |
| 50 | MP0001984_abnormal_olfaction | 1.10511358 |
| 51 | MP0000343_altered_response_to | 1.07530619 |
| 52 | MP0002971_abnormal_brown_adipose | 1.07344055 |
| 53 | MP0004043_abnormal_pH_regulation | 1.06814062 |
| 54 | MP0005503_abnormal_tendon_morphology | 1.06608225 |
| 55 | MP0000003_abnormal_adipose_tissue | 1.06500335 |
| 56 | MP0006072_abnormal_retinal_apoptosis | 1.06112618 |
| 57 | MP0002736_abnormal_nociception_after | 1.06082255 |
| 58 | MP0002933_joint_inflammation | 1.04296103 |
| 59 | MP0002938_white_spotting | 1.00116875 |
| 60 | MP0005377_hearing/vestibular/ear_phenot | 0.97602749 |
| 61 | MP0003878_abnormal_ear_physiology | 0.97602749 |
| 62 | MP0005508_abnormal_skeleton_morphology | 0.97468198 |
| 63 | MP0009785_altered_susceptibility_to | 0.96491520 |
| 64 | MP0002332_abnormal_exercise_endurance | 0.95638512 |
| 65 | MP0004859_abnormal_synaptic_plasticity | 0.94288657 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 0.94026798 |
| 67 | MP0005390_skeleton_phenotype | 0.93250643 |
| 68 | MP0009046_muscle_twitch | 0.92786173 |
| 69 | MP0000751_myopathy | 0.92772751 |
| 70 | MP0005334_abnormal_fat_pad | 0.92457576 |
| 71 | MP0010329_abnormal_lipoprotein_level | 0.91687404 |
| 72 | MP0002295_abnormal_pulmonary_circulatio | 0.90892803 |
| 73 | MP0005253_abnormal_eye_physiology | 0.89788872 |
| 74 | MP0002998_abnormal_bone_remodeling | 0.89161809 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.87896394 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 0.86248428 |
| 77 | MP0002090_abnormal_vision | 0.85823164 |
| 78 | MP0002108_abnormal_muscle_morphology | 0.84517250 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.84036970 |
| 80 | MP0005164_abnormal_response_to | 0.82717396 |
| 81 | MP0003633_abnormal_nervous_system | 0.81631879 |
| 82 | MP0008775_abnormal_heart_ventricle | 0.80911449 |
| 83 | MP0009384_cardiac_valve_regurgitation | 0.80028863 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.78772854 |
| 85 | MP0005671_abnormal_response_to | 0.78757744 |
| 86 | MP0001764_abnormal_homeostasis | 0.78692648 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.78261387 |
| 88 | MP0002115_abnormal_skeleton_extremities | 0.77607470 |
| 89 | MP0002638_abnormal_pupillary_reflex | 0.73585876 |
| 90 | MP0004133_heterotaxia | 0.72802372 |
| 91 | MP0002972_abnormal_cardiac_muscle | 0.72757653 |
| 92 | MP0002572_abnormal_emotion/affect_behav | 0.71354541 |
| 93 | MP0004264_abnormal_extraembryonic_tissu | 0.71075945 |
| 94 | MP0003091_abnormal_cell_migration | 0.70653523 |
| 95 | MP0003880_abnormal_central_pattern | 0.70385379 |
| 96 | MP0001440_abnormal_grooming_behavior | 0.70204655 |
| 97 | MP0004130_abnormal_muscle_cell | 0.69211827 |
| 98 | MP0009250_abnormal_appendicular_skeleto | 0.68958395 |
| 99 | MP0009764_decreased_sensitivity_to | 0.68785982 |
| 100 | MP0001905_abnormal_dopamine_level | 0.68319518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Failure to thrive in infancy (HP:0001531) | 7.25558188 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.94717801 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.94717801 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.94717801 |
| 5 | Febrile seizures (HP:0002373) | 4.06659362 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.78214379 |
| 7 | Spondylolisthesis (HP:0003302) | 3.77845751 |
| 8 | Asymmetric septal hypertrophy (HP:0001670) | 3.43837966 |
| 9 | Amniotic constriction ring (HP:0009775) | 3.29632944 |
| 10 | Abnormality of placental membranes (HP:0011409) | 3.29632944 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.11417068 |
| 12 | Mutism (HP:0002300) | 2.87799287 |
| 13 | Abnormality of lateral ventricle (HP:0030047) | 2.87221333 |
| 14 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.81095423 |
| 15 | Apathy (HP:0000741) | 2.76074066 |
| 16 | Peritonitis (HP:0002586) | 2.63074901 |
| 17 | Diminished motivation (HP:0000745) | 2.57079281 |
| 18 | Rib fusion (HP:0000902) | 2.55762136 |
| 19 | Disinhibition (HP:0000734) | 2.49975073 |
| 20 | Aortic aneurysm (HP:0004942) | 2.47637596 |
| 21 | Papillary thyroid carcinoma (HP:0002895) | 2.47178081 |
| 22 | Severe visual impairment (HP:0001141) | 2.47058181 |
| 23 | Ankle contracture (HP:0006466) | 2.44764999 |
| 24 | Spontaneous abortion (HP:0005268) | 2.43418990 |
| 25 | Generalized aminoaciduria (HP:0002909) | 2.42806129 |
| 26 | Nausea (HP:0002018) | 2.39147533 |
| 27 | Progressive external ophthalmoplegia (HP:0000590) | 2.35994357 |
| 28 | Potter facies (HP:0002009) | 2.34517842 |
| 29 | Facial shape deformation (HP:0011334) | 2.34517842 |
| 30 | Abnormality of dental color (HP:0011073) | 2.34115522 |
| 31 | Atrophic scars (HP:0001075) | 2.29700742 |
| 32 | Glucose intolerance (HP:0000833) | 2.28965039 |
| 33 | Gowers sign (HP:0003391) | 2.27192439 |
| 34 | Loss of speech (HP:0002371) | 2.24318849 |
| 35 | Severe global developmental delay (HP:0011344) | 2.24029142 |
| 36 | Decreased subcutaneous fat (HP:0001002) | 2.23970807 |
| 37 | Chin dimple (HP:0010751) | 2.23856554 |
| 38 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.20836160 |
| 39 | Poor head control (HP:0002421) | 2.20342265 |
| 40 | Absent/shortened dynein arms (HP:0200106) | 2.19753822 |
| 41 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19753822 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 2.16296597 |
| 43 | Nonprogressive disorder (HP:0003680) | 2.16007567 |
| 44 | Axonal loss (HP:0003447) | 2.13419577 |
| 45 | Soft skin (HP:0000977) | 2.12200633 |
| 46 | Chronic hepatic failure (HP:0100626) | 2.06604581 |
| 47 | Methylmalonic acidemia (HP:0002912) | 2.06440058 |
| 48 | Fatigable weakness (HP:0003473) | 2.04407209 |
| 49 | Abnormality of the neuromuscular junction (HP:0003398) | 2.04407209 |
| 50 | Aortic dissection (HP:0002647) | 2.03105919 |
| 51 | Coxa valga (HP:0002673) | 2.02925756 |
| 52 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.02821742 |
| 53 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.00622090 |
| 54 | Narrow forehead (HP:0000341) | 1.99112411 |
| 55 | Easy fatigability (HP:0003388) | 1.96861988 |
| 56 | Split foot (HP:0001839) | 1.96464513 |
| 57 | Congenital sensorineural hearing impairment (HP:0008527) | 1.96252241 |
| 58 | Follicular hyperkeratosis (HP:0007502) | 1.93289861 |
| 59 | Reduced antithrombin III activity (HP:0001976) | 1.91933672 |
| 60 | Prolonged neonatal jaundice (HP:0006579) | 1.87421407 |
| 61 | Hoarse voice (HP:0001609) | 1.85315494 |
| 62 | Rhabdomyolysis (HP:0003201) | 1.84933504 |
| 63 | Anhidrosis (HP:0000970) | 1.82819035 |
| 64 | Exercise-induced myalgia (HP:0003738) | 1.82681398 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81646686 |
| 66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81646686 |
| 67 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81646686 |
| 68 | Eosinophilia (HP:0001880) | 1.80944527 |
| 69 | Increased number of teeth (HP:0011069) | 1.80901696 |
| 70 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.80737162 |
| 71 | Abnormality of methionine metabolism (HP:0010901) | 1.79668285 |
| 72 | Hypoplastic ischia (HP:0003175) | 1.79554514 |
| 73 | Abnormality of the frontal sinuses (HP:0002687) | 1.79506836 |
| 74 | Popliteal pterygium (HP:0009756) | 1.79343483 |
| 75 | Neonatal short-limb short stature (HP:0008921) | 1.77956940 |
| 76 | Hypoalphalipoproteinemia (HP:0003233) | 1.77223106 |
| 77 | Medial flaring of the eyebrow (HP:0010747) | 1.76228353 |
| 78 | Malignant hyperthermia (HP:0002047) | 1.75099307 |
| 79 | Aortic regurgitation (HP:0001659) | 1.73385976 |
| 80 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.72895623 |
| 81 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.72895623 |
| 82 | Knee flexion contracture (HP:0006380) | 1.71831878 |
| 83 | Premature rupture of membranes (HP:0001788) | 1.70450542 |
| 84 | Sudden death (HP:0001699) | 1.69919312 |
| 85 | Spinal rigidity (HP:0003306) | 1.68796877 |
| 86 | Intestinal atresia (HP:0011100) | 1.67956012 |
| 87 | Optic neuritis (HP:0100653) | 1.67288207 |
| 88 | Retrobulbar optic neuritis (HP:0100654) | 1.67288207 |
| 89 | Orchitis (HP:0100796) | 1.66729908 |
| 90 | Muscular dystrophy (HP:0003560) | 1.65423868 |
| 91 | Fetal akinesia sequence (HP:0001989) | 1.65338326 |
| 92 | Abnormality of macular pigmentation (HP:0008002) | 1.64412507 |
| 93 | Type 2 muscle fiber atrophy (HP:0003554) | 1.64398298 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.64012692 |
| 95 | Mucopolysacchariduria (HP:0008155) | 1.64012692 |
| 96 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.63840230 |
| 97 | Persistence of primary teeth (HP:0006335) | 1.61724764 |
| 98 | Erythroderma (HP:0001019) | 1.61676414 |
| 99 | Beaking of vertebral bodies (HP:0004568) | 1.61241003 |
| 100 | Abnormality of the calf musculature (HP:0001430) | 1.61062085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 6.07203404 |
| 2 | FGFR3 | 3.60693429 |
| 3 | TAF1 | 2.89182727 |
| 4 | STK38L | 2.77786808 |
| 5 | MARK3 | 2.64170979 |
| 6 | MAP3K6 | 2.60315485 |
| 7 | MAP4K2 | 2.41152176 |
| 8 | MYLK | 2.37308386 |
| 9 | DDR2 | 2.20728012 |
| 10 | MAP2K7 | 2.12916600 |
| 11 | MUSK | 2.11995324 |
| 12 | MAP3K4 | 2.01449684 |
| 13 | STK38 | 1.98393330 |
| 14 | PINK1 | 1.95609729 |
| 15 | WNK3 | 1.94296666 |
| 16 | BMPR1B | 1.87190707 |
| 17 | KIT | 1.85101532 |
| 18 | DYRK1A | 1.81855550 |
| 19 | BLK | 1.75356439 |
| 20 | GRK7 | 1.70700956 |
| 21 | MAP3K5 | 1.60758309 |
| 22 | MATK | 1.57261378 |
| 23 | FLT3 | 1.55217277 |
| 24 | PKN1 | 1.43428770 |
| 25 | PRKD2 | 1.42763498 |
| 26 | DYRK1B | 1.40283205 |
| 27 | ACVR1B | 1.39639428 |
| 28 | BRSK2 | 1.39582749 |
| 29 | CASK | 1.36866268 |
| 30 | MOS | 1.22118219 |
| 31 | OBSCN | 1.18306018 |
| 32 | CLK1 | 1.16638201 |
| 33 | FGR | 1.13177849 |
| 34 | MARK2 | 1.09028225 |
| 35 | CDK3 | 1.08740801 |
| 36 | TAOK2 | 1.08705326 |
| 37 | CAMKK2 | 1.08680965 |
| 38 | JAK3 | 1.04041593 |
| 39 | CDC42BPA | 1.02283527 |
| 40 | PRPF4B | 0.98953513 |
| 41 | MAP2K4 | 0.95079637 |
| 42 | PLK4 | 0.94470518 |
| 43 | PTK2B | 0.93842246 |
| 44 | MAPK13 | 0.92598679 |
| 45 | CDK19 | 0.92265943 |
| 46 | TRPM7 | 0.90905358 |
| 47 | EIF2AK1 | 0.88256221 |
| 48 | ADRBK2 | 0.88066346 |
| 49 | WNK1 | 0.87823339 |
| 50 | MAPK12 | 0.86355554 |
| 51 | DAPK3 | 0.78353866 |
| 52 | TGFBR2 | 0.76264833 |
| 53 | CSF1R | 0.72995208 |
| 54 | TGFBR1 | 0.72688376 |
| 55 | ROCK1 | 0.69886405 |
| 56 | PIK3CG | 0.66456042 |
| 57 | PRKACB | 0.62798759 |
| 58 | PRKAA2 | 0.62374484 |
| 59 | AKT3 | 0.59573715 |
| 60 | ZAP70 | 0.58290409 |
| 61 | CCNB1 | 0.57750351 |
| 62 | PAK2 | 0.56748526 |
| 63 | DMPK | 0.55837298 |
| 64 | TIE1 | 0.54740770 |
| 65 | TYK2 | 0.54727631 |
| 66 | LATS2 | 0.54015599 |
| 67 | PKN2 | 0.53181255 |
| 68 | JAK1 | 0.52554961 |
| 69 | PRKD3 | 0.52328279 |
| 70 | FRK | 0.51302192 |
| 71 | CHUK | 0.49701193 |
| 72 | CAMK1 | 0.49406367 |
| 73 | PRKG1 | 0.49346913 |
| 74 | INSR | 0.48585771 |
| 75 | PRKG2 | 0.48321168 |
| 76 | TESK1 | 0.47778534 |
| 77 | PLK2 | 0.46201729 |
| 78 | INSRR | 0.44169232 |
| 79 | BRD4 | 0.41860429 |
| 80 | MAP3K7 | 0.41033677 |
| 81 | STK10 | 0.40673806 |
| 82 | ADRBK1 | 0.40533188 |
| 83 | IRAK3 | 0.40419430 |
| 84 | PIM2 | 0.37939431 |
| 85 | LATS1 | 0.37858310 |
| 86 | RET | 0.37698789 |
| 87 | ERBB3 | 0.36974118 |
| 88 | PRKCE | 0.36960859 |
| 89 | ERN1 | 0.36188409 |
| 90 | ABL1 | 0.35314865 |
| 91 | MAPKAPK3 | 0.35104848 |
| 92 | PRKAA1 | 0.34321881 |
| 93 | MAP3K13 | 0.33411718 |
| 94 | RIPK1 | 0.32887807 |
| 95 | NEK9 | 0.31448712 |
| 96 | ERBB4 | 0.30636070 |
| 97 | TBK1 | 0.29512698 |
| 98 | IGF1R | 0.29294694 |
| 99 | NTRK2 | 0.27419493 |
| 100 | CAMK4 | 0.26760866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.31809350 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.29977578 |
| 3 | Basal transcription factors_Homo sapiens_hsa03022 | 2.20676912 |
| 4 | Circadian rhythm_Homo sapiens_hsa04710 | 2.20419189 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.11548755 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.04804993 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.01384339 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 1.99726015 |
| 9 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.92691030 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.85752678 |
| 11 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.80860472 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 1.80748734 |
| 13 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.74952964 |
| 14 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.74825613 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.73476154 |
| 16 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.65445181 |
| 17 | Amoebiasis_Homo sapiens_hsa05146 | 1.64497738 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61051356 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.54997646 |
| 20 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.54198861 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.50948632 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.41485537 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.39534710 |
| 24 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.33325735 |
| 25 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.32060916 |
| 26 | Focal adhesion_Homo sapiens_hsa04510 | 1.30821751 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.29627110 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.27757006 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.27018864 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.26250561 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20249419 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16678977 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.13522718 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12835708 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10964558 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.10904772 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09308309 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.09306426 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.06501642 |
| 40 | Olfactory transduction_Homo sapiens_hsa04740 | 1.05147112 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02466059 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01717909 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01534403 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01428890 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92431990 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 0.91875985 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85716291 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83646832 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83636715 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83500074 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82261925 |
| 52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.79289105 |
| 53 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78852840 |
| 54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78252888 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77323862 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76106613 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75792046 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74955779 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73819628 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72120964 |
| 61 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.71351095 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71053626 |
| 63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68035690 |
| 64 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.67315302 |
| 65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65815629 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64999078 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64389984 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62416974 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61840791 |
| 70 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61602885 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60302395 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59004995 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57374800 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57275849 |
| 75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54726207 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54260869 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52014540 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51704114 |
| 79 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.51115361 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50113795 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48768698 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47402533 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46450869 |
| 84 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45432735 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.45222766 |
| 86 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45027113 |
| 87 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44006967 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43450507 |
| 89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43053735 |
| 90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43008035 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41317275 |
| 92 | Morphine addiction_Homo sapiens_hsa05032 | 0.39906958 |
| 93 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37700149 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37431902 |
| 95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37157208 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36459922 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36299449 |
| 98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.35646682 |
| 99 | Tuberculosis_Homo sapiens_hsa05152 | 0.35320500 |
| 100 | Peroxisome_Homo sapiens_hsa04146 | 0.35049139 |

